Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1610-1615
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1610
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1610
Table 1 Patient’s characteristics n (%)
Age, mean ± SD, yr | 50.5 ± 12 |
Sex, M/F | 2/57 |
Symptoms | |
Biliary | 47 (79.6) |
Pancreatic | 9 (15.2) |
Biliopancreatic | 3 (5) |
Occurrence of painful episodes | |
Once a week | 9 (15.8) |
Once a month | 20 (35.1) |
Every 3 mo | 9 (15.8) |
Every 6 mo | 3 (5.3) |
Once a year | 7 (12.3) |
Dilatation of biliary or pancreatic ducts | |
(bile duct > 12 mm; pancreatic duct > 4 mm) | |
Main biliary duct dilatation | 29 (49.1) |
Main pancreatic duct dilatation | 1 (1.7) |
Milwaukee classification repartition | |
Type 1 | 11 (18.6) |
Type 2 | 34 (57.6) |
Type 3 | 14 (23.7) |
Initial elevation of laboratory data | 34 (57.6) |
Lengthening of the isotopic transit time | 32 (54.2) |
- Citation: Vitton V, Ezzedine S, Gonzalez JM, Gasmi M, Grimaud JC, Barthet M. Medical treatment for sphincter of oddi dysfunction: Can it replace endoscopic sphincterotomy? World J Gastroenterol 2012; 18(14): 1610-1615
- URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1610.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1610